-

Global Vitreo Retinal Surgery Devices Pipeline Report 2022 Update: Formulate Significant Competitor Information, Analysis, and Insights to Improve R&D Strategies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Scope

  • Extensive coverage of the Vitreo Retinal Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vitreo Retinal Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Products under Development

3.1 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development

3.2 Vitreo Retinal Surgery Devices - Pipeline Products by Territory

3.3 Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path

3.4 Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date

3.5 Vitreo Retinal Surgery Devices - Ongoing Clinical Trials

4 Vitreo Retinal Surgery Devices - Pipeline Products under Development by Companies

4.1 Vitreo Retinal Surgery Devices Companies - Pipeline Products by Stage of Development

4.2 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development

5 Vitreo Retinal Surgery Devices Companies and Product Overview

5.1 ABVC BioPharma Inc Company Overview

5.2 AcuSurgical Company Overview

5.3 Alcon Inc Company Overview

5.4 Bausch & Lomb Inc Company Overview

5.5 Beaver-Visitec International Inc Company Overview

5.6 Boston College Company Overview

5.7 Cambridge Polymer Group Inc Company Overview

5.8 Carnegie Mellon University Company Overview

5.9 Duke University Company Overview

5.10 Dutch Ophthalmic Research Center International BV Company Overview

5.11 Johns Hopkins University Company Overview

5.12 King's College London Company Overview

5.13 Medisse BV (Inactive) Company Overview

5.14 RetinaSense Company Overview

5.15 Synergetics USA, Inc. (Inactive) Company Overview

5.16 The Chinese University of Hong Kong Company Overview

5.17 University of Kansas Company Overview

5.18 University of Minnesota Company Overview

6 Vitreo Retinal Surgery Devices- Recent Developments

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/zd122m

Source: GlobalData

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Computer System Validation (CSV) Training Course: Regulations Impacting Your Systems and Hands-on Practice Writing Validation Documents (Jan 27th - Jan 29th, 2026 & On-Demand) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Computer System Validation (CSV) Training Course (Jan 27th - Jan 29th, 2026)" training has been added to ResearchAndMarkets.com's offering. A course designed to completely immerse you in computer system validation. This course delivers comprehension of the regulations impacting your systems and hands-on practice writing validation documents. You will leave ready to lead efficient, effective, inspection- ready validation projects. Registration Includes: Checklist of...

Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions Webinar - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Understanding Medical Device Regulatory Pathways - 510(k), PMA & Exemptions (January 15, 2026)" training has been added to ResearchAndMarkets.com's offering. This expert-led 3-hour webinar provides a comprehensive introduction to the key regulatory pathways for medical device submissions in the US market. The regulation and control of new or substantially changed medical devices for sale in the US is based on the 510(k), PMA or DeNovo submission process. This w...

Medical Devices: Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) Course: Developing Effective Post Market Surveillance and Complaint Handling Systems Training - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Medical Devices: Developing Effective Post Market Surveillance and Complaint Handling Systems Course (Jan 22nd - Jan 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. What are U.S. FDA CGMP expectations/requirements for Post Market Surveillance and Complaint Handling? This seminar will examine Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act), as well as appropriate articles / Annexes of the EU's MDR, which require manu...
Back to Newsroom